The Tomosynthesis Mammography Imaging Screening Trial (TMIST), the first large-scale breast cancer screening trial in nearly 25 years, has been approved for funding by the National Cancer Institute (NCI). The ECOG-ACRIN Cancer Research Group (ECOG- ACRIN) leading the trial is now recruiting medical facilities as it prepares to open the trial in mid-2017.

Hospitals should consider mock magnetic resonance imaging (MRI) sessions, MR-compatible audiovisual systems and feed-sleep manipulation strategies before sedating pediatric patients preparing for MR procedures, according to a new study.

Utah-based healthcare technology company Novarad will be exhibiting its ChameleonDR digital radiography solution at the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Nov. 27-Dec. 3 in Chicago.

Sure, the Radiological Society of North America’s (RSNA) annual meeting disrupts Thanksgiving. And the cold wind coming off Lake Michigan makes it all the harder to leave family and friends. But it’s easy to love RSNA, especially the exhibit floor. 

Computer programs have defeated humans in Jeopardy!, chess and Go. Now a program developed at Case Western Reserve University has outperformed physicians on a more serious matter.

Dicerna Pharmaceuticals Inc. announced in September that the company will focus its resources on its proprietary GalXC technology platform to advance development of product candidates in its core therapeutic areas. Those areas include rare diseases, chronic liver diseases, cardiovascular disease and viral infectious diseases. Under this plan, Dicerna will transition its primary hyperoxaluria (PH) development program to focus on DCR-PHXC, a subcutaneously delivered GalXC clinical candidate, which was announced earlier this year.

A new study by Logicalis examined the significant challenges facing chief information officers (CIOs) worldwide as they enable businesses in every market segment to respond to threats posed by digital disrupters like Uber and Airbnb. The 2016 Logicalis Global CIO Survey, now in its fourth year, polled over 700 CIOs worldwide. According to the survey, distributed IT, shadow IT departments and data security are among the biggest issues facing CIOs today.

For men with intermediate-risk prostate cancer, radiation treatment with brachytherapy alone can result in similar cancer control with fewer long-term side effects. The findings come from research presented at the 58th annual meeting of the American Society for Radiation Oncology (ASTRO) comparing brachytherapy alone to more aggressive treatment that combines brachytherapy with external beam therapy (EBT).

Calgary Scientific announced it will be displaying its flagship ResolutionMD technology at the 2016 annual meeting of the Radiological Society of North America (RSNA), Nov. 27-Dec. 3 in Chicago.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now